Susquehanna International Group, LLP Pacific Biosciences Of California, Inc. Transaction History

Susquehanna International Group, LLP

$688 Billion
Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,282,635 shares of PACB stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,282,635

Previous 348,013 268.56%

Holding current value

$1.55 Million

Previous $410,000 287.8%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.91 - $1.45 $850,506 - $1.36 Million	934,622 Added 268.56%	1,282,635 $1.59 Million
Q1 2025 May 14, 2025	SELL	$1.14 - $2.1 $595,789 - $1.1 Million	-522,622 Reduced 60.03%	348,013 $410,000
Q4 2024 Feb 14, 2025	SELL	$1.55 - $2.65 $1.33 Million - $2.27 Million	-858,229 Reduced 49.64%	870,635 $1.59 Million
Q3 2024 Nov 14, 2024	BUY	$1.2 - $2.17 $1.09 Million - $1.98 Million	911,103 Added 111.41%	1,728,864 $2.94 Million
Q2 2024 Aug 15, 2024	BUY	$1.36 - $3.65 $391,877 - $1.05 Million	288,145 Added 54.41%	817,761 $1.12 Million
Q1 2024 May 07, 2024	SELL	$3.52 - $9.59 $832,652 - $2.27 Million	-236,549 Reduced 30.87%	529,616 $1.99 Million
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $3.11 Million - $5.39 Million	520,223 Added 211.52%	766,165 $7.52 Million
Q3 2023 Nov 14, 2023	SELL	$8.23 - $13.93 $352,515 - $596,663	-42,833 Reduced 14.83%	245,942 $2.05 Million
Q2 2023 Aug 11, 2023	BUY	$9.97 - $14.05 $1.77 Million - $2.5 Million	177,979 Added 160.64%	288,775 $3.84 Million
Q1 2023 May 16, 2023	SELL	$7.94 - $12.02 $1.02 Million - $1.55 Million	-128,791 Reduced 53.76%	110,796 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$5.67 - $11.2 $834,771 - $1.65 Million	147,226 Added 159.4%	239,587 $1.96 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $75,279 - $164,158	-19,155 Reduced 17.18%	92,361 $537,000
Q2 2022 Aug 15, 2022	BUY	$4.02 - $10.43 $383,729 - $995,595	95,455 Added 594.33%	111,516 $493,000
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $715,083 - $1.77 Million	-84,826 Reduced 84.08%	16,061 $146,000
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $231,794 - $362,012	12,035 Added 13.54%	100,887 $2.06 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $450,015 - $633,932	18,102 Added 25.59%	88,852 $2.27 Million
Q2 2021 Aug 11, 2021	SELL	$22.3 - $36.02 $3.59 Million - $5.8 Million	-161,056 Reduced 69.48%	70,750 $2.47 Million
Q1 2021 May 17, 2021	SELL	$26.38 - $51.15 $9.48 Million - $18.4 Million	-359,471 Reduced 60.8%	231,806 $7.72 Million
Q4 2020 Feb 16, 2021	BUY	$10.5 - $28.5 $3.49 Million - $9.46 Million	331,949 Added 128.0%	591,277 $15.3 Million
Q3 2020 Nov 16, 2020	BUY	$3.61 - $9.87 $770,359 - $2.11 Million	213,396 Added 464.59%	259,328 $2.56 Million
Q2 2020 Aug 14, 2020	SELL	$2.65 - $4.03 $128,063 - $194,753	-48,326 Reduced 51.27%	45,932 $158,000
Q1 2020 May 15, 2020	BUY	$2.36 - $5.26 $188,967 - $421,173	80,071 Added 564.4%	94,258 $289,000
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $419,667 - $508,162	-91,232 Reduced 86.54%	14,187 $73,000
Q3 2019 Nov 14, 2019	BUY	$4.99 - $6.16 $257,913 - $318,385	51,686 Added 96.19%	105,419 $544,000
Q2 2019 Aug 16, 2019	BUY	$5.92 - $7.41 $238,345 - $298,334	40,261 Added 298.85%	53,733 $325,000
Q4 2018 Feb 14, 2019	SELL	$3.99 - $7.82 $119,033 - $233,294	-29,833 Reduced 68.89%	13,472 $100,000
Q3 2018 Nov 14, 2018	SELL	$3.52 - $5.55 $402,603 - $634,786	-114,376 Reduced 72.54%	43,305 $234,000
Q4 2017 Feb 14, 2018	BUY	$2.59 - $5.44 $197,233 - $414,266	76,152 Added 93.4%	157,681 $416,000
Q3 2017 Nov 14, 2017	BUY	$3.2 - $5.57 $260,892 - $454,116	81,529	81,529 $428,000

Others Institutions Holding PACB

# of Institutions

243

Shares Held

199M

Call Options Held

879K

Put Options Held

847K

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $272M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Pacific Biosciences Of California, Inc. Transaction History